Objective
=========

To evaluate current rates and temporal trends in adherence with national guidelines recommending chlamydia test-of-cure for pregnant females and test-of-reinfection for all patients.

Introduction
============

Sexually transmitted disease treatment guidelines have incrementally added repeat testing recommendations for *Chlamydia trachomatis* infections over time, including test-of-cure 3 to 4 weeks following completion of treatment for pregnant women and test-of-reinfection for all patients approximately 3 months after infection. However, few studies have investigated adherence to these recommendations and whether the evolution of guidelines have led to changes in repeat testing patterns over time.

Methods
=======

The Electronic medical record Support for Public Health surveillance network (ESPnet) was leveraged to analyze electronic health record data for three independent practice groups serving approximately 20% of the Massachusetts population. We identified all cases with laboratory-confirmed *Chlamydia trachomatis* infections between 2010 and 2015 and evaluated the frequency, timing, and results of subsequent chlamydia tests in the following year.

Results
=======

Between 2010 and 2015, 972 pregnant female cases, 10,309 non-pregnant female cases, and 4,973 male cases had a positive *C. trachomatis* laboratory result. Test-of-cure within 3-5 weeks following an index positive test occurred in 36.8% of pregnant females. Test- of-reinfection within 2-4 months of an index test occurred in 39.2% of pregnant females, 17.9% of non-pregnant females, and 9.0% of males. There were no significant increases in test-of-cure or test-of- reinfection rates over the study period for any groups. Among cases with repeat tests, 15.9% of pregnant females, 14.6% of non-pregnant females, and 16.3% of males had at least one repeat positive result within one year of the index positive result.

Conclusions
===========

Chlamydia test-of-cure and test-of-reinfection rates are low, with no evidence of improvement over time. There are substantial opportunities to improve adherence to chlamydia repeat testing recommendations.
